XML 52 R32.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segment and Related Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2014
Schedule of Segment Performance Based on Income (Loss) from Continuing Operations before Interest Income and Other Income and Expense | The accounting policies of the segments are the same as those described in the summary of significant accounting policies (Note 1). The Company evaluates segment performance based on income (loss) before interest income and other income and expense.
(In thousands) |  | Research |  |  | Molecular diagnostics |  |  | Pharmaceutical & clinical services |  |  | Total |
Year ended June 30, 2014: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | — |  |  | $ | 748,198 |  |  | $ | 30,018 |  |  | $ | 778,216 |
Depreciation and amortization |  |  | 2,001 |  |  |  | 9,887 |  |  |  | 1,931 |  |  |  | 13,819 |
Segment operating income (loss) |  |  | (64,981 | ) |  |  | 338,020 |  |  |  | 1,403 |  |  |  | 274,442 |
Year ended June 30, 2013: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | — |  |  | $ | 582,392 |  |  | $ | 30,773 |  |  | $ | 613,165 |
Depreciation and amortization |  |  | 2,182 |  |  |  | 4,974 |  |  |  | 1,733 |  |  |  | 8,889 |
Segment operating income (loss) |  |  | (56,428 | ) |  |  | 291,509 |  |  |  | (7,079 | ) |  |  | 228,002 |
Year ended June 30, 2012: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | — |  |  | $ | 472,390 |  |  | $ | 23,615 |  |  | $ | 496,005 |
Depreciation and amortization |  |  | 2,021 |  |  |  | 5,395 |  |  |  | 1,653 |  |  |  | 9,069 |
Segment operating income (loss) |  |  | (49,231 | ) |  |  | 237,737 |  |  |  | (8,188 | ) |  |  | 180,318 |
|  | Years Ended June 30, |
(In thousands) |  | 2014 |  |  | 2013 |  |  | 2012 |
Total operating income for reportable segments |  | $ | 274,442 |  |  | $ | 228,002 |  |  | $ | 180,318 |
Unallocated amounts: |  |  |  |  |  |  |  |  |  |  |  |
Interest income |  |  | 5,397 |  |  |  | 5,497 |  |  |  | 4,629 |
Other |  |  | (1,974 | ) |  |  | (223 | ) |  |  | (407 | )
Income from operations before income taxes |  |  | 277,865 |  |  |  | 233,276 |  |  |  | 184,540 |
Income tax provision |  |  | 101,640 |  |  |  | 86,137 |  |  |  | 72,389 |
Net income |  | $ | 176,225 |  |  | $ | 147,139 |  |  | $ | 112,151 |
Schedule Of Comparison of Balance Sheet Assets by Operating Segment | The following table sets forth a comparison of balance sheet assets by operating segment:
(In thousands) |  | June 30, |
|  | 2014 |  |  | 2013 |
Net equipment and leasehold improvements: |  |  |  |  |  |  |  |
Research |  | $ | 8,199 |  |  | $ | 8,590 |
Molecular diagnostics |  |  | 24,316 |  |  |  | 15,769 |
Pharmaceutical and clinical services |  |  | 2,079 |  |  |  | 3,243 |
Total |  | $ | 34,594 |  |  | $ | 27,602 |
Total Assets: |  |  |  |  |  |  |  |
Research |  | $ | 67,999 |  |  | $ | 82,517 |
Molecular diagnostics |  |  | 409,795 |  |  |  | 110,329 |
Pharmaceutical and clinical services |  |  | 75,434 |  |  |  | 79,911 |
Total |  | $ | 553,228 |  |  | $ | 272,757 |
Reconciliation of Assets by Operating Segment to Total Assets | The following table reconciles assets by operating segment to total assets:
|  | June 30, |
(In thousands) |  | 2014 |  |  | 2013 |
Total assets by segment |  | $ | 553,228 |  |  | $ | 272,757 |
Cash, cash equivalents, and marketable investment securities (1) |  |  | 270,586 |  |  |  | 531,064 |
Total |  | $ | 823,814 |  |  | $ | 803,821 |
| (1) | The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments

X
- Definition Schedule Of Comparison Of Balance Sheet Assets By Operating Segment + References No definition available. + Details
Name: | mygn_ScheduleOfComparisonOfBalanceSheetAssetsByOperatingSegmentTableTextBlock
Namespace Prefix: | mygn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8721-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration